BE900563A - Composition pharmaceutique pour le traitement d'etats d'insuffisance renale aigue. - Google Patents

Composition pharmaceutique pour le traitement d'etats d'insuffisance renale aigue.

Info

Publication number
BE900563A
BE900563A BE0/213640A BE213640A BE900563A BE 900563 A BE900563 A BE 900563A BE 0/213640 A BE0/213640 A BE 0/213640A BE 213640 A BE213640 A BE 213640A BE 900563 A BE900563 A BE 900563A
Authority
BE
Belgium
Prior art keywords
treatment
pharmaceutical composition
acute kidney
kidney deficiency
administration
Prior art date
Application number
BE0/213640A
Other languages
English (en)
Inventor
V Bonomini
Original Assignee
Crinos Industria Farmaco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinos Industria Farmaco filed Critical Crinos Industria Farmaco
Publication of BE900563A publication Critical patent/BE900563A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'admistration d'un médicament, contenant du défibrotide comme substance active, dans le cas d'insuffisances rénales aigues accompagnées de microangiopathies thrombotiques, permet d'arreter l'évolution de la situation clinique vers la chronicité et, dans un grand nombre de cas, d0obtenir une rémission complèe. L'administration peut se faire soit par voie intraveineuse ou intramusculaire soit par voie orale.
BE0/213640A 1983-09-12 1984-09-12 Composition pharmaceutique pour le traitement d'etats d'insuffisance renale aigue. BE900563A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22856/83A IT1170215B (it) 1983-09-12 1983-09-12 Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta

Publications (1)

Publication Number Publication Date
BE900563A true BE900563A (fr) 1985-01-02

Family

ID=11201234

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/213640A BE900563A (fr) 1983-09-12 1984-09-12 Composition pharmaceutique pour le traitement d'etats d'insuffisance renale aigue.

Country Status (8)

Country Link
US (1) US4649134A (fr)
EP (1) EP0137542B1 (fr)
JP (1) JPH0647546B2 (fr)
AT (1) ATE65696T1 (fr)
BE (1) BE900563A (fr)
CH (1) CH661871A5 (fr)
DE (1) DE3433329A1 (fr)
IT (1) IT1170215B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170214B (it) * 1983-09-12 1987-06-03 Crinos Industria Farmaco Composizione farmaceutica per la cura delle arteriopatie periferiche
IT1190313B (it) * 1986-04-17 1988-02-16 Crinos Industria Farmaco Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante
US5223609A (en) * 1986-04-17 1993-06-29 Crinos Industria Farmacobiologica S.P.A. Process for obtaining chemically defined and reproducible polydeoxyribonucleotides
IT1223322B (it) * 1987-10-23 1990-09-19 Crinos Industria Farmaco Metodo per prevenire la formazione di coaguli sanguigni nel circuito extracorporeo di apparecchi di dialisi a composizione utile per esso
IT1231509B (it) * 1989-09-07 1991-12-07 Crinos Industria Farmaco Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.
US6699985B2 (en) * 1991-08-21 2004-03-02 Arsinur Burcoglu Method of treating HIV infection and related secondary infections thereof
US5977083A (en) * 1991-08-21 1999-11-02 Burcoglu; Arsinur Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
US5624912A (en) * 1991-08-21 1997-04-29 Burcoglu; Arsinur Method of treating HIV infection and related secondary infections with defibrotide
AU692433B2 (en) * 1993-01-13 1998-06-11 Arsinur Burcoglu Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
AU754242B2 (en) * 1997-04-28 2002-11-07 Arsinur Burcoglu Method of treating HIV infection and related secondary infections thereof
EP1325962A1 (fr) * 2001-12-17 2003-07-09 Gentium S.p.A. Procédé pour la détermination de l'activité biologique de la defibrotide
EP1872787A1 (fr) * 2006-06-27 2008-01-02 Gentium S.p.A. Utilisation de defibrotide pour l'inhibition de l'heparanase
EP1982722A1 (fr) * 2007-04-16 2008-10-22 Gentium S.p.A. Utilisation de oligotide pour le traitement de maladies rénales
WO2009065171A1 (fr) 2007-11-19 2009-05-28 Cochlear Limited Rangée d'électrodes pour implant cochléaire
EP2103689A1 (fr) * 2008-03-19 2009-09-23 Gentium S.p.A. Oligonucléotides phosphodiesters synthétiques et leurs utilisations thérapeutiques
IT1406068B1 (it) 2010-07-22 2014-02-06 Medestea Int Spa Polidesossiribonucleotidi (pdrn) per l'impiego nel trattamento di condizioni di acidosi e composizioni a base di polidesossiribonucleotidi per il suddetto impiego
DK2637672T3 (en) 2010-11-12 2018-10-22 Gentium S R L DEFIBROTID FOR USE IN PROPHYLAXY AND / OR TREATMENT OF GRAPHIC VERSUS HOST DISEASE (GVHD)
KR102038357B1 (ko) * 2012-06-22 2019-10-31 젠티엄 에스알엘 디파이브로타이드의 생물학적 활성 측정을 위한 유우글로불린에 기초한 방법
EP3026122A1 (fr) 2014-11-27 2016-06-01 Gentium S.p.A. Procédé à base cellulaire pour déterminer la puissance de défibrotide
RU2766143C2 (ru) * 2017-07-26 2022-02-08 Джентиум С.Р.Л. Жидкая композиция дефибротида для лечения и профилактики веноокклюзионной болезни
CN111132663A (zh) * 2017-08-03 2020-05-08 爵士制药爱尔兰有限公司 包含高浓度核酸的制剂
AU2019252790A1 (en) 2018-04-12 2020-10-15 Jazz Pharmaceuticals, Inc. Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion
EP4135717A1 (fr) 2020-04-17 2023-02-22 Jazz Pharmaceuticals Ireland Limited Traitement de défibrotide pour la prévention d'un rejet et d'une lésion d'organe
TW202308659A (zh) 2021-05-06 2023-03-01 愛爾蘭商爵士製藥愛爾蘭有限責任公司 用於急性呼吸窘迫症候群之治療及預防的去纖維蛋白多核苷酸

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB879622A (en) * 1959-07-13 1961-10-11 Farmaceutici Italia Steroids
DE1202439B (de) * 1959-11-24 1965-10-07 Cediap Centrale De Destributio Verfahren zur Herstellung von Praeparaten mit hohem Gehalt an freien Desoxyribonucleinsaeuren aus Fischmilch
FR2575M (fr) * 1962-03-19 1964-06-08 Cediap Centrale De Distrib D A Procédé de préparation d'un médicament a base d'adn (acide désoxyribonucléique) en milieu vital d'origine et produit nouveau en résultant.
IT1043823B (it) * 1970-11-03 1980-02-29 Prephar Procedimento per l estrazione di acidi nucleici da organi animali
US3899481A (en) * 1970-11-03 1975-08-12 Crinos Industria Farmaco Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs
DE2154279A1 (de) * 1970-11-03 1972-05-25 Crinos Industria Farmaco Medikamente für das fibrinolytische System

Also Published As

Publication number Publication date
IT8322856A0 (it) 1983-09-12
JPS6084224A (ja) 1985-05-13
ATE65696T1 (de) 1991-08-15
DE3433329A1 (de) 1985-03-28
EP0137542B1 (fr) 1991-07-31
JPH0647546B2 (ja) 1994-06-22
CH661871A5 (it) 1987-08-31
EP0137542A3 (en) 1987-09-02
US4649134A (en) 1987-03-10
EP0137542A2 (fr) 1985-04-17
IT1170215B (it) 1987-06-03
DE3433329C2 (fr) 1993-07-22

Similar Documents

Publication Publication Date Title
FR2347044A1 (fr) Compositions pharmaceutiques contenant comme ingredients actifs des derives de triazolo-pyrimidines utiles pour le traitement de psoriasis
OA08617A (fr) Inhibiteurs de métalloendopeptidase neutre dans le traitement de l'hypertention.
BE900660A (fr) Composition therapeutique pour le traitement des sequelles d'intoxication.
BE1002249A4 (fr) Compositions pharmaceutiques.
TNSN96104A1 (fr) Trihydrate de metahensulfonate de (1s,2s)-1-(4-hydroxyphenyl) -2-(4-hydroxy-4-phenylpiperidine-1-yl)-1-propanol et composition pharmaceutique le contenant
FR2440371A1 (fr) Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
FR2378523A1 (fr) Medicament pour le traitement de l'acne
FR2419758A1 (fr) Composition de gel
BE1002109A3 (fr) Composition pharmaceutique a activite analgesique.
BE900564A (fr) Composition pharmaceutique pour le traitement d'arteriopathies peripheriques.
EP0137542A3 (en) Pharmaceutical composition for the treatment of states of acute renal insufficiency
FR2453649A1 (fr) Composition pharmaceutique a action prolongee contenant des acides biliaires utile notamment pour la lyse des calculs
BE891639A (fr) Compositions pharmaceutiques contenant de la gamma-butyro-betaine pour le traitement de syndromes provoques par une deficience en l-carnitine
TNSN01115A1 (fr) Composition en particules contenant de l'eletriptan, et procede pour sa production
BE901301A (fr) 5-pyrimidine-carboxamides et thiocarboamides, ainsi que le traitement de la leucemie et des tumeurs avec ces substances.
BE761444A (fr) Nouvelles compositions pharmaceutiques pour le traitement d'infections microbiennes
BE829859A (fr) Procedes et compositions pharmaceutiques pour le traitement de l'hypercholesterolemie
BE825653A (fr) Compositions pharmaceutiques antibiotiques contenant le sel de sodium de l'acide 7- (d-2-formyloxy-2- phenylace tamido -3- 1-methyl-14-tetrazole-5-yl-thiomethyl)-3-cephem-40-carboxylique
FR2503149B1 (fr) Esters de mercaptoacyl-carnitines, procede pour leur preparation et leurs utilisations therapeutiques, notamment dans le traitement des intoxications et des brulures et en tant qu'agents mucolytiques
DK464483A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende et fibrinolytisk middel
BE904846A (fr) Steroides 11beta-substitues utiles notamment dans le traitement des tumeurs hormono-dependantes et procede pour la fabrication.
FR2383665A1 (fr) Nouvelle composition therapeutique a base de trans broparestrol
FR2375206A1 (fr) Nouvelles isothiourees, procede pour les preparer et compositions pharmaceutiques les contenant
FR2380778A1 (fr) Compositions pharmaceutiques contenant des acides oxaniliques substitues ou leurs esters
FR2515516B1 (fr) Composition pharmaceutique pour le traitement de la lithiase renale infectee contenant de l'acide propionohydroxamique ou ses sels acceptables en pharmacie

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: CRINOS INDUSTRIA FARMACOBIOLOGICA S.P.A.

Effective date: 19970930